Objectives: We examined whether plasma concentrations of amyloid beta (Aβ) as protein derivatives play a central role in the etiology of autistic features.Design and Methods: Concentrations of human Aβ (1-42), Aβ (1-40), and Aβ (40/42) in the plasma of 52 autistic children (aged 3-16 years) and 36 age-matched control subjects were determined by using the ELISA technique and were compared.Results: Compared to control subjects, autistic children exhibited significantly lower concentrations of both Aβ (1-40) and Aβ (1-42) and lower Aβ (40/42) concentration ratio. Receiver operating characteristics curve (ROC) analysis showed that these measurements of Aβ peptides showed high specificity and sensitivity in distinguishing autistic children from control subjects.Conclusions: Lower concentrations of Aβ (1-42) and Aβ (1-40) were attributed to loss of Aβ equilibrium between the brain and blood, an imbalance that may lead to failure to draw Aβ from the brain and/or impairment of β- and γ- secretase's concentration or kinetics as enzymes involving in Aβ production. © 2012 Al- Ayadhi et al; licensee BioMed Central Ltd.
Al- Ayadhi, L. Y., Ben Bacha, A. G., Kotb, M., & El-Ansary, A. K. (2012). A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics. Behavioral and Brain Functions, 8. https://doi.org/10.1186/1744-9081-8-4